SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) – Equities research analysts at Edison Inv. Res issued their FY2024 earnings per share (EPS) estimates for SIGA Technologies in a research note issued to investors on Monday, November 18th. Edison Inv. Res analyst J. Prakash anticipates that the company will post earnings of $1.04 per share for the year. Edison Inv. Res also issued estimates for SIGA Technologies’ FY2025 earnings at $1.25 EPS.
SIGA Technologies (NASDAQ:SIGA – Get Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.02 earnings per share (EPS) for the quarter. The firm had revenue of $10.01 million for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%.
SIGA Technologies Stock Up 0.3 %
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of SIGA. Price T Rowe Associates Inc. MD boosted its position in shares of SIGA Technologies by 8.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 29,180 shares of the company’s stock valued at $250,000 after purchasing an additional 2,218 shares during the period. Rhumbline Advisers boosted its position in shares of SIGA Technologies by 4.2% in the 2nd quarter. Rhumbline Advisers now owns 69,947 shares of the company’s stock valued at $531,000 after purchasing an additional 2,851 shares during the period. Linden Thomas Advisory Services LLC boosted its position in shares of SIGA Technologies by 27.0% in the 2nd quarter. Linden Thomas Advisory Services LLC now owns 15,871 shares of the company’s stock valued at $120,000 after purchasing an additional 3,370 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of SIGA Technologies by 38.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,684 shares of the company’s stock valued at $104,000 after purchasing an additional 3,829 shares during the period. Finally, Larson Financial Group LLC acquired a new position in shares of SIGA Technologies in the 3rd quarter valued at $30,000. 55.40% of the stock is owned by institutional investors and hedge funds.
SIGA Technologies Company Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Featured Stories
- Five stocks we like better than SIGA Technologies
- What is Put Option Volume?
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Why Are Stock Sectors Important to Successful Investing?
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Why is the Ex-Dividend Date Significant to Investors?
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.